171 related articles for article (PubMed ID: 3263689)
1. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase.
Washington JA; Knapp CC; Sanders CC
Rev Infect Dis; 1988; 10(4):824-9. PubMed ID: 3263689
[TBL] [Abstract][Full Text] [Related]
2. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
Sanders CC; Sanders WE
J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamase.
Knapp CC; Washington JA
J Clin Microbiol; 1992 Jan; 30(1):214-5. PubMed ID: 1734054
[TBL] [Abstract][Full Text] [Related]
4. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
Shannon K; Phillips I
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
[TBL] [Abstract][Full Text] [Related]
5. Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
Acar JF; Minozzi C
Rev Infect Dis; 1986; 8 Suppl 5():S482-6. PubMed ID: 3541133
[TBL] [Abstract][Full Text] [Related]
6. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
Curtis NA; Eisenstadt RL; Rudd C; White AJ
J Antimicrob Chemother; 1986 Jan; 17(1):51-61. PubMed ID: 3485092
[TBL] [Abstract][Full Text] [Related]
7. Detection of gram-negative β-lactamase producing pathogens in the clinical lab.
Thomson KS
Curr Pharm Des; 2013; 19(2):250-6. PubMed ID: 22894616
[TBL] [Abstract][Full Text] [Related]
8. Induction potency of various beta-lactam derivatives in gram-negative rods.
Cullmann W; Dick W
Chemotherapy; 1989; 35(1):43-53. PubMed ID: 2785904
[TBL] [Abstract][Full Text] [Related]
9. Importance of beta-lactamase induction.
Phillips I; Shannon K
Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S19-26. PubMed ID: 8477758
[TBL] [Abstract][Full Text] [Related]
10. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
Richmond MH
Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
[TBL] [Abstract][Full Text] [Related]
11. The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.
Stapleton P; Shannon K; Phillips I
J Antimicrob Chemother; 1995 Sep; 36(3):483-96. PubMed ID: 8830012
[TBL] [Abstract][Full Text] [Related]
12. beta-Lactamases of gram-negative bacteria: new challenges for new drugs.
Sanders CC
Clin Infect Dis; 1992 May; 14(5):1089-99. PubMed ID: 1600011
[TBL] [Abstract][Full Text] [Related]
13. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--I. Steady-state treatment.
Frère JM
Biochem Pharmacol; 1989 May; 38(9):1415-26. PubMed ID: 2785796
[TBL] [Abstract][Full Text] [Related]
14. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
Dudley M
Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
Pitout JD; Sanders CC; Sanders WE
Am J Med; 1997 Jul; 103(1):51-9. PubMed ID: 9236486
[TBL] [Abstract][Full Text] [Related]
16. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
Livermore DM
Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
Matsumura N; Minami S; Mitsuhashi S
J Antimicrob Chemother; 1997 Jan; 39(1):31-4. PubMed ID: 9044025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
